| pubmed-article:2880767 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2880767 | lifeskim:mentions | umls-concept:C0156543 | lld:lifeskim |
| pubmed-article:2880767 | lifeskim:mentions | umls-concept:C0242172 | lld:lifeskim |
| pubmed-article:2880767 | lifeskim:mentions | umls-concept:C0043210 | lld:lifeskim |
| pubmed-article:2880767 | lifeskim:mentions | umls-concept:C0002680 | lld:lifeskim |
| pubmed-article:2880767 | lifeskim:mentions | umls-concept:C0025872 | lld:lifeskim |
| pubmed-article:2880767 | lifeskim:mentions | umls-concept:C0262926 | lld:lifeskim |
| pubmed-article:2880767 | lifeskim:mentions | umls-concept:C0332119 | lld:lifeskim |
| pubmed-article:2880767 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
| pubmed-article:2880767 | lifeskim:mentions | umls-concept:C1524063 | lld:lifeskim |
| pubmed-article:2880767 | lifeskim:mentions | umls-concept:C1456501 | lld:lifeskim |
| pubmed-article:2880767 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:2880767 | pubmed:dateCreated | 1987-4-1 | lld:pubmed |
| pubmed-article:2880767 | pubmed:abstractText | In a double-blind controlled trial the efficacy of prophylactic metronidazole and pivampicillin to women with a history of pelvic inflammatory disease (PID) undergoing first-trimester abortion was assessed. Thirty-eight women received pivampicillin tablets 350 mg and 43 women metronidazole tablets 400 mg, given 1 h before and 4 and 8 h after the abortion. In the pivampicillin group 5 women (13.1%) and in the metronidazole group 8 women (18.6%) developed post-abortal PID, a non-significant difference (P greater than 0.05). The number of hospital days and amounts of antibiotics were not significantly different in the two treatment groups (all P-values greater than 0.05). Women with a history of PID were found to be at risk of contracting postabortal PID. | lld:pubmed |
| pubmed-article:2880767 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2880767 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2880767 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2880767 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2880767 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2880767 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2880767 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2880767 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:2880767 | pubmed:issn | 0020-7292 | lld:pubmed |
| pubmed-article:2880767 | pubmed:author | pubmed-author:PetersenKK | lld:pubmed |
| pubmed-article:2880767 | pubmed:author | pubmed-author:SørensenS SSS | lld:pubmed |
| pubmed-article:2880767 | pubmed:author | pubmed-author:HeisterbergLL | lld:pubmed |
| pubmed-article:2880767 | pubmed:author | pubmed-author:NielsenDD | lld:pubmed |
| pubmed-article:2880767 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2880767 | pubmed:volume | 24 | lld:pubmed |
| pubmed-article:2880767 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2880767 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2880767 | pubmed:pagination | 343-6 | lld:pubmed |
| pubmed-article:2880767 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:2880767 | pubmed:meshHeading | pubmed-meshheading:2880767-... | lld:pubmed |
| pubmed-article:2880767 | pubmed:meshHeading | pubmed-meshheading:2880767-... | lld:pubmed |
| pubmed-article:2880767 | pubmed:meshHeading | pubmed-meshheading:2880767-... | lld:pubmed |
| pubmed-article:2880767 | pubmed:meshHeading | pubmed-meshheading:2880767-... | lld:pubmed |
| pubmed-article:2880767 | pubmed:meshHeading | pubmed-meshheading:2880767-... | lld:pubmed |
| pubmed-article:2880767 | pubmed:meshHeading | pubmed-meshheading:2880767-... | lld:pubmed |
| pubmed-article:2880767 | pubmed:meshHeading | pubmed-meshheading:2880767-... | lld:pubmed |
| pubmed-article:2880767 | pubmed:meshHeading | pubmed-meshheading:2880767-... | lld:pubmed |
| pubmed-article:2880767 | pubmed:meshHeading | pubmed-meshheading:2880767-... | lld:pubmed |
| pubmed-article:2880767 | pubmed:meshHeading | pubmed-meshheading:2880767-... | lld:pubmed |
| pubmed-article:2880767 | pubmed:meshHeading | pubmed-meshheading:2880767-... | lld:pubmed |
| pubmed-article:2880767 | pubmed:meshHeading | pubmed-meshheading:2880767-... | lld:pubmed |
| pubmed-article:2880767 | pubmed:meshHeading | pubmed-meshheading:2880767-... | lld:pubmed |
| pubmed-article:2880767 | pubmed:year | 1986 | lld:pubmed |
| pubmed-article:2880767 | pubmed:articleTitle | Comparison of preventive use of metronidazole and ampicillin in women with a history of pelvic inflammatory disease undergoing first-trimester abortion. | lld:pubmed |
| pubmed-article:2880767 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2880767 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:2880767 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:2880767 | pubmed:publicationType | Controlled Clinical Trial | lld:pubmed |
